Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

Virginia G. Kaklamani, MD, DSc, discusses how effective elacestrant (Orserdu) is in CDK4/6 inhibitor-naive estrogen ...

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug—which is ...

Real-world study compares the efficacy and safety of axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel), ...

Adding pyrotinib to trastuzumab and docetaxel prolonged progression-free survival in patients with HER2-positive metastatic breast cancer.

"Golden Bachelor" star Gerry Turner announced he has bone marrow cancer. His form of bone marrow is considered to be incurable but the five-year survival rate is 78%.

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative ...

Survival in multiple myeloma has improved significantly with the advent of novel, more potent immunotherapies, including CAR ...

Praise Is The Cure, a faith-based breast cancer awareness program for Black women, also reaches out to the men who have been ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Treatments developed at St. Jude Children’s Research Hospital have helped push the overall childhood cancer survival rate from 20 percent to more than 80 percent since the hospital opened ...

Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...